Technetium-99m radiolabeling and biological study of epirubicin for in vivo imaging of multi-drug-resistant Staphylococcus aureus infections via single photon emission computed tomography

Chemical Biology & Drug Design
N U H KhanAmeer Fawad Zahoor

Abstract

The development of functional imaging is a promising strategy for diagnosis and treatment of infectious and cancerous diseases. In this study, epirubicin was developed as a [99m Tc]-labeled radiopharmaceutical for the imaging of multi-drug-resistant Staphylococcus aureus infections. The labeling was carried out using sodium pertechnetate (Na99m TcO4 ; ~370 MBq). The other parameters such as amount of ligand, reducing agent (SnCl2 .2H2 O), and pH were optimized. The highest labeling yield ≥96.98% was achieved when 0.3 mg epirubicin, 13 μg SnCl2 .2H2 O, and ~370 MBq Na99m TcO4 were incubated at pH 7 for 15 min in the presence of ascorbic acid at room temperature. Radiochemical purity, stability, charge, and glomerular filtration rate were studied to evaluate the biological compatibility for in vivo administration. Biodistribution investigations showed radiotracer uptake (13.89 ± 1.56% ID/gm organ) by liver and 7.79 ± 0.38% ID/gm organ by kidneys at 30 min post-injection which promisingly wash out at 24 hr post-injection. Scintigraphy study showed selective uptake in S. aureus-infected tissues in contrast to turpentine oil-induced inflamed tissues. Target-to-non-target ratio (6.7 ± 0.05) was calculated at 1 hr post-injection using...Continue Reading

References

Jan 1, 1983·Investigational New Drugs·G Robustelli Della CunaF Ganzina
Oct 27, 2004·Journal of Magnetic Resonance Imaging : JMRI·Laurence AnnetBernard E Van Beers
May 24, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K B LauplandUNKNOWN International Bacteremia Surveillance Collaborative
Dec 15, 2015·Bioinformatics·Edoardo MilanettiAnna Tramontano
Jul 23, 2016·Journal of Labelled Compounds & Radiopharmaceuticals·Rashid RasheedShahid Rasheed
Feb 10, 2017·Journal of Labelled Compounds & Radiopharmaceuticals·Rashid RasheedNidda Saeed
Sep 19, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·Syed Ali Raza Naqvi, Karl Drlica

❮ Previous
Next ❯

Citations

Feb 26, 2021·Dose-response : a Publication of International Hormesis Society·Samina RoohiSyed Ali Raza Naqvi
Jul 29, 2020·Current Medicinal Chemistry·Mengshi LiMichael K Schultz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.